Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model

Gene Therapy

Volumn 17, Issue 10, 2010, Pages 1262-1269

  Zhang, L ^a,b   Jia, T H ^b   Chong, A C M ^a   Bai, L ^a   Yu, H ^a   Gong, W ^b   Wooley, P H ^a   Yang, S Y ^a  

^a Orthopaedic Research Institute Incorporated   (United States)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

aseptic loosening; cell based therapy; implant stability; osteoprotegerin; periprosthetic osteolysis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CD68 ANTIGEN; INTERLEUKIN 1BETA; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL BASED GENE THERAPY; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROSTHESIS LOOSENING; SYNOVIOCYTE; TRANSGENE; TREATMENT OUTCOME;

ACID PHOSPHATASE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; GENE THERAPY; GENETIC VECTORS; ISOENZYMES; KNEE PROSTHESIS; MICE; MICE, INBRED BALB C; OSTEOLYSIS; OSTEOPROTEGERIN; PROSTHESIS FAILURE; WEIGHT-BEARING;

MURINAE; MUS;

EID: 77957990313     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.64     Document Type: Article

References (30)

1. Holt G, Murnaghan C, Reilly J, Meek RM. The biology of aseptic osteolysis. Clin Orthop Relat Res 2007; 460: 240-252.
2. Purdue PE, Koulouvaris P, Potter HG, Nestor BJ, Sculco TP. The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop Relat Res 2007; 454: 251-261.
3. Suzuki Y, Nishiyama T, Hasuda K, Fujishiro T, Niikura T, Hayashi S et al. Effect of etidronate on COX-2 expression and PGE(2) production in macrophage-like RAW 264.7 cells stimulated by titanium particles. J Orthop Sci 2007; 12: 568-577.
4. Kim KJ, Chiba J, Rubash HE. In vivo and in vitro analysis of membranes from hip prostheses inserted without cement. J Bone Joint Surg Am 1994; 76: 172-180.
5. Shanbhag AS, Jacobs JJ, Black J, Galante JO, Glant TT. Cellular mediators secreted by interfacial membranes obtained at revision total hip arthroplasty. J Arthroplasty 1995; 10: 498-506.
6. Cooper RA, McAllister CM, Borden LS, Bauer TW. Polyethylene debris-induced osteolysis and loosening in uncemented total hip arthroplasty. A cause of late failure. J Arthroplasty 1992; 7: 285-290.
7. Bell NH. RANK ligand and the regulation of skeletal remodeling. J Clin Invest 2003; 111: 1120-1122.
8. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289: 1504-1508.
9. Takahashi N, Udagawa N, Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun 1999; 256: 449-455. (Pubitemid 29301126)
10. Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 2000; 97: 1566-1571.
11. Kim N, Odgren PR, Kim DK, Marks Jr SC, Choi Y. Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc Natl Acad Sci USA 2000; 97: 10905-10910.
12. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-319.
13. Yang SY, Yu H, Gong W, Wu B, Mayton L, Costello R et al. Murine model of prosthesis failure for the long-term study of aseptic loosening. J Orthop Res 2007; 25: 603-611.
14. Goater JJ, O'Keefe RJ, Rosier RN, Puzas JE, Schwarz EM. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res 2002; 20: 169-173.
15. Zhang T, Yu H, Gong W, Zhang L, Jia T, Wooley PH et al. The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure. Biomaterials 2009; 30: 6102-6108.
16. Ulrich-Vinther M, Carmody EE, Goater JJ, Balle KS, O'Keefe RJ, Schwarz EM. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am 2002; 84-A: 1405-1412.
17. Yang SY, Mayton L, Wu B, Goater JJ, Schwarz EM, Wooley PH. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. Arthritis Rheum 2002; 46: 2514-2523.
18. Harris WH. Wear and periprosthetic osteolysis: the problem. Clin Orthop Relat Res 2001, 393: 66-70.
19. Dumbleton JH, Manley MT, Edidin AA. A literature review of the association between wear rate and osteolysis in total hip arthroplasty. J Arthroplasty 2002; 17: 649-661.
20. Schmalzried TP, Jasty M, Harris WH. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg Am 1992; 74: 849-863.
21. Purdue PE, Koulouvaris P, Nestor BJ, Sculco TP. The central role of wear debris in periprosthetic osteolysis. HSS J 2006; 2: 102-113.
22. Yang SY, Wu B, Mayton L, Mukherjee P, Robbins PD, Evans CH et al. Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis. Gene Ther 2004; 11: 483-491.
23. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 1990; 87: 7260-7264.
24. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165-176.
25. Hofbauer LC. Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. Eur J Endocrinol 1999; 141: 195-210.
26. Yang S, Wu B, Mayton L, Evans CH, Robbins PD, Wooley PH. IL-1Ra and vIL-10 gene transfer using retroviral vectors ameliorates particle-associated inflammation in the murine air pouch model. Inflamm Res 2002; 51: 342-350.
27. Chang YS, Kobayashi M, Li ZL, Oka M, Nakamura T. Significance of peak value and duration of the interfacial shear load in evaluation of the bone-implant interface. Clin Biomech (Bristol, Avon) 2003; 18: 773-779.
28. Li P, Sanz I, O'Keefe RJ, Schwarz EM. NF-kappa B regulates VCAM-1 expression on fibroblast-like synoviocytes. J Immunol 2000; 164: 5990-5997.
29. Geiler T, Kriegsmann J, Keyszer GM, Gay RE, Gay S. A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum 1994; 37: 1664-1671.
30. Wooley PH, Petersen S, Song Z, Nasser S. Cellular immune responses to orthopaedic implant materials following cemented total joint replacement. J Orthop Res 1997; 15: 874-880.